These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17147301)

  • 1. [Aspirin for the primary prevention of cardiovascular diseases in diabetic patients. A review of currently available tests].
    Maciá Bobes C; Ronzón Fernández A; Fernández García E
    Rev Esp Salud Publica; 2006; 80(6):613-20. PubMed ID: 17147301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
    Stavrakis S; Stoner JA; Azar M; Wayangankar S; Thadani U
    Am J Med Sci; 2011 Jan; 341(1):1-9. PubMed ID: 21191260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
    Gilpin VL; ; ;
    J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of aspirin for primary prevention of cardiovascular events in diabetic patients--is it justified?].
    Benhamou Y; Lévesque H
    Rev Med Interne; 2009 Dec; 30(12):1001-3. PubMed ID: 19833416
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
    Schnell O; Erbach M; Hummel M
    Diab Vasc Dis Res; 2012 Oct; 9(4):245-55. PubMed ID: 22508698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus.
    Younis N; Williams S; Soran H
    Diabetes Obes Metab; 2009 Nov; 11(11):997-1000. PubMed ID: 19531055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aspirin as primary prevention for diabetic patients].
    Fumeaux D; Becerra ME; Philippe J; Louis-Simonet M
    Rev Med Suisse; 2010 Feb; 6(234):244-8. PubMed ID: 20334083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aspirin for primary prevention of cardiovascular diseases in diabetic patients: focus on gender difference and insulin resistance].
    Legrand DA; Scheen AJ
    Rev Med Liege; 2006 Oct; 61(10):682-90. PubMed ID: 17209500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy for primary prevention in diabetes.
    Ambrosi P; Villani P; Bouvenot G
    Diabetes Metab; 2006 Sep; 32 Spec No2():2S52-6. PubMed ID: 17375409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
    Sacco M; Pellegrini F; Roncaglioni MC; Avanzini F; Tognoni G; Nicolucci A;
    Diabetes Care; 2003 Dec; 26(12):3264-72. PubMed ID: 14633812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspirin therapy for cardiovascular prevention in the diabetic patient: what have we learned from the evidence?].
    Legrand DA; Scheen AJ
    Rev Med Suisse; 2006 Aug; 2(76):1904-8. PubMed ID: 16972540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].
    Legrand DA; Scheen AJ
    Rev Med Liege; 2007 Oct; 62(10):610-5. PubMed ID: 18069572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of aspirin in the primary prevention of cardiovascular disease].
    Rodondi N; Cornuz J
    Rev Med Suisse; 2006 Mar; 2(56):646-51. PubMed ID: 16597054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
    Ajjan RA
    Diab Vasc Dis Res; 2012 Oct; 9(4):243-4. PubMed ID: 22942227
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin for primary prevention of cardiovascular disease in diabetes mellitus.
    Pignone M; Williams CD
    Nat Rev Endocrinol; 2010 Nov; 6(11):619-28. PubMed ID: 20856266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary prevention, aspirin and diabetes].
    Balaguer Vintró I
    Rev Esp Salud Publica; 2006; 80(6):609-12. PubMed ID: 17147300
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acetylsalicylic acid for the primary prevention of cardiovascular disease in diabetic patients].
    de Lange DW; Fiets WE; Banga JD
    Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1481-5. PubMed ID: 15481570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Should we treat all diabetic patients with aspirin in primary prevention?].
    Righetti A; De Moerloose P; Philippe J
    Rev Med Suisse; 2005 Jun; 1(22):1500-4. PubMed ID: 16025889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.